Correction and Clarification
Correction and Clarification
Our article "Yellow light on pain relievers" in the June 2007 issue inaccurately listed Actiq as a pain reliever for people with heart disease. The drug is approved only for breakthrough cancer pain.
Arnold Robbins, M.D., a psychiatrist in Cambridge, Mass., took exception to the American Heart Association's recommendation of narcotics as an option for pain relief, given their potential for addiction. "The rule for opiates is to recommend them rarely and only as a last resort and only to patients you feel you know and understand," Dr. Robbins wrote us. In other words, narcotic pain relievers should be used only in special cases.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.